Latest Breaking News On - Invasive fungal disease - Page 1 : comparemela.com

Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis

Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtUnited statesNils schrMarc engelhardtStevens johnsonJournal of the pediatric infectious diseases societyAstellas pharma us incEuropean commissionEuropean medicines agencyBasilea pharmaceutica ltdHead of corporate communications investor relationsSwiss exchangeDrug administrationEuropean unionPharmaceutica ltd

FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis

/PRNewswire/ Astellas Pharma US, Inc. (President: Mark Reisenauer, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved.

United statesStevens johnsonAntonioc arrietaMark reisenauerLynn fenicchiaDrug administrationPrnewswire astellas pharma us incBasilea pharmaceutica international ltdAstellas pharma us incChildren health of orangeAstellas pharma incPediatric infectious diseaseSpecialties business unitMedical mycologyInvasive aspergillosisSafety information

FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis

FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesLynn fenicchiaStevens johnsonAntonioc arrietaMark reisenauerAstellas pharma us incChildren health of orangeDrug administrationAstellas pharma incBasilea pharmaceutica international ltdPrnewswire astellas pharma us incPediatric infectious diseaseSpecialties business unitMedical mycologyInvasive aspergillosisSafety information

U S FDA Accepts Astellas sNDA for CRESEMBA® (isavuconazonium sulfate) in Children

/PRNewswire/ Astellas Pharma US, Inc. (President: Mark Reisenauer, "Astellas") announced that the U.S. Food and Drug Administration (FDA) has accepted the.

Stevens johnsonLynn fenicchiaZoi dorotheaTadaaki taniguchiMark reisenauerDrug administrationPrnewswire astellas pharma us incAstellas pharma us incAstellas pharma incNew drug applicationPrescription drug user fee actSpecialties business unitInvasive aspergillosisSafety informationAdverse drug reactionsRelated reactions

Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market 2021 – Research Scope, Regi

Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market 2021 – Research Scope, Regi
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth africaSaudi arabiaCanada generalInstitut virionserion gmbMark stoneDynamiker biotechnology tianjin co ltdZhanjiangac biological ltdAssociates of cape cod incHead of business developmentGlobal invasive fungal diseaseInfection diagnostic reagent market growthInvasive fungal diseaseInfection diagnostic reagentCape cod